Prof. Giannaccare | PBM in the Management of Dry AMD: 12-month results from the LightWave I Multicentric Clinical Trial

Can photobiomodulation help change the course of dry AMD?

Join Prof. Giuseppe Giannaccare in this webinar presenting the 12-month findings from the LightWave I multicentric clinical trial on photobiomodulation in early and intermediate dry AMD. The session will explore how specific wavelengths of light may support mitochondrial function, reduce oxidative stress, and positively impact retinal structure and visual function.

Topics covered include:

• The role of mitochondrial dysfunction in dry AMD
• Yellow and red light photobiomodulation protocols
• Multicenter randomized clinical trial design
• Changes in drusen volume and visual acuity over time
• Safety outcomes and prevention of disease progression

Learn how photobiomodulation may represent a promising, non-invasive strategy to support retinal health and potentially modify disease progression in dry AMD patients.

The event will be followed by a LIVE Q&A session with Espansione's Medical Affairs Team.

Can’t attend live? Register anyway to receive the webinar replay.